×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [304]
复旦大学上海医学... [302]
中国医学科学院 ... [292]
武汉大学 [100]
西安交通大学 [91]
吉林大学白求恩第一... [84]
更多...
内容类型
期刊论文 [1677]
会议论文 [49]
学位论文 [7]
发表日期
2022 [19]
2021 [24]
2020 [21]
2019 [265]
2018 [287]
2017 [266]
更多...
学科主题
Oncology [3]
oncology; ... [3]
oncology [2]
oncology; ... [2]
radiology,... [2]
Biochemist... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共1733条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study
期刊论文
EBIOMEDICINE, 2022, 卷号: 86, 页码: 13
作者:
She, Yunlang
;
He, Bingxi
;
Wang, Fang
;
Zhong, Yifan
;
Wang, Tingting
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2023/02/22
Deep learning
Neoadjuvant chemoimmunotherapy
Major pathological response
Non-small cell lung cancer
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
期刊论文
CANCER MEDICINE, 2022
作者:
Yu, Xiaoqing
;
Si, Jinfei
;
Wei, Jingwen
;
Wang, Yanling
;
Sun, Yan
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/23
EGFR-TKIs
non-small cell lung cancer (NSCLC)
real-world study
survival outcome
Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Xu, Yuan-rui
;
Wang, An-long
;
Li, Ya-qing
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
chronic obstructive pulmonary disease
lung cancer
non-small cell lung cancer
hypoxia-inducible factor 1-alpha
hypoxia-inducible factor 1
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Guo-Zhen
;
Ma, Li-Ying
;
Zhang, Zong-Hui
;
Wang, Xiao-Lin
;
Hua, Jing-Han
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/12/22
small-cell lung cancer
H3
3
PARP1
PARP inhibitor
darinaparsin
combination treatment
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wei, Jingwen
;
Xiang, Jing
;
Hao, Yue
;
Si, Jinfei
;
Wang, Wenxian
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/22
Anemia
Epidermal growth factor receptor
Epidermal growth factor receptor tyrosine kinase inhibitors
Non-small cell lung cancer
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety
期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:
Shao, Lan
;
Lou, Guangyuan
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/22
Neoadjuvant
immunotherapy
immune-checkpoint inhibitors
non-small cell lung cancer (NSCLC)
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
期刊论文
CANCERS, 2022, 卷号: 14
作者:
Xie, Mingying
;
Li, Na
;
Xu, Xiaoling
;
Xu, Yanjun
;
Li, Hui
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/22
liver metastasis
non-small cell lung cancer
PD-L1
PD-1
PD-L1 inhibitor
CD8+T cell
Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Lu, S.
;
Jian, H.
;
Zhang, Y.
;
Song, Z.
;
Zhao, Y.
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
KRAS G12C mutation
Small molecular inhibitor
Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Xu, X.
;
Li, N.
;
Fan, Y.
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/23
ALK
non-small cell lung cancer (NSCLC)
leptomeningeal metastases (LM)
Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Fu, Meng
;
Feng, Chun-Mei
;
Xia, Da-Qing
;
Ji, Zi-Mei
;
Xia, Huai-Ling
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2022/12/23
savolitinib
MET exon 14 skipping
neoadjuvant therapy
non-small cell lung cancer
targeted therapy
©版权所有 ©2017 CSpace - Powered by
CSpace